Dow Jones Top Company Headlines at 9 AM ET: Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer's Trials | Performance ...
Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer's Trials
Oral semaglutide-a key ingredient in obesity and diabetes drugs Ozempic and Wegovy-didn't slow Alzheimer's disease in two late-stage clinical trials.
----
Performance Food Group, US Foods Scrap Merger Talks
Performance Food Group and US Foods Holdings have called off talks to merge in a deal that would have created a food-distribution giant rivaling top player Sysco
----
AI Meets Aggressive Accounting at Meta's Gigantic New Data Center
Favorable treatment off the balance sheet hinges on some convenient assumptions.
----
BHP Abandons Bid for Anglo American Following New Talks
BHP Group won't pursue a takeover of Anglo American, clearing the way for Anglo's merger with Teck Resources.
----
Rheinmetall Turns to Former Auto Workers to Fuel Hiring Spree
EXCLUSIVE: Rheinmetall is looking to tap workers laid off by the car industry as it prepares to quintuple sales by 2030 compared with 2024.
----
Tech Investor Prosus Posts Higher Profit, Driven by Tencent Holding
Higher profitability at Tencent and the group's e-commerce operations, as well as a $3.3 billion gain from trimming its stake in the tech giant, contributed to the result.
----
Bayer Shares Jump After Drug Candidate Shows Stroke Prevention Potential
The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during the study.
----
Julius Baer Draws Line Under Credit Review With New Charge
The bank is turning the page on a set of legacy issues with the conclusion of a credit review under which it is taking another large provision for bad property loans.
----
Owner of U.K.'s Daily Mail Nears Deal to Buy Rival Daily Telegraph
The $655 million deal would end a controversial sale process and create a powerhouse in British right-wing media.
----
How Google Finally Leapfrogged Rivals With New Gemini Rollout
Gemini 3's surge past ChatGPT and other competitors on benchmark tests has handed Google an elusive victory.
----
'Wicked: For Good' Scores Huge Box Office Opening
The musical sequel made its debut with an estimated $150 million in the U.S. and Canada in a boost to movie theaters.
(END) Dow Jones Newswires
November 24, 2025 09:15 ET (14:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
This Once-Hot AI Stock Now Looks Deeply Undervalued
The 10 Best Companies to Invest in Now
He Tried Shorting Jim Cramer’s Stock Picks. It Cost Him More Than Money
United States